Pyrimethamine-loaded lipid-core nanocapsules to improve drug efficacy for the treatment of toxoplasmosis

被引：16

作者：

Pissinate, Kenia ^{[1
,4
]}

Martins-Duarte, Erica dos Santos ^{[1
,2
]}

Schaffazick, Scheila Rezende ^{[1
,3
]}

de Oliveira, Catiuscia Padilha ^{[3
]}

Vommaro, Rossiane Claudia ^{[1
,2
]}

Guterres, Silvia Staniscuaski ^{[3
]}

Pohlmann, Adriana Raffin ^{[3
,4
]}

de Souza, Wanderley ^{[1
,2
,5
]}

机构：

[1] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil

[2] Univ Fed Rio Grande do Sul, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, BR-91501970 Porto Alegre, RS, Brazil

[3] Univ Fed Rio Grande do Sul, Fac Farm, Programa Posgrad Ciencias Farmaceut, BR-91501970 Porto Alegre, RS, Brazil

[4] Univ Fed Rio Grande do Sul, Inst Quim, Dept Quim Organ, BR-91501970 Porto Alegre, RS, Brazil

[5] Inst Nacl Metrol & Qualidade Ind Inmetro, Rio De Janeiro, Brazil

来源：

PARASITOLOGY RESEARCH | 2014年 / 113卷 / 02期

关键词：

DIHYDROFOLATE-REDUCTASE; NANOMEDICINES; CHALLENGES; INHIBITORS; SIZE;

D O I：

10.1007/s00436-013-3715-6

中图分类号：

R38 [医学寄生虫学]; Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ; 100103 ;

摘要：

We propose an innovative product based on the nanoencapsulation of pyrimethamine (PYR), aiming an improvement of drug efficacy for the treatment of toxoplasmosis. The in vitro cytotoxicity effect of encapsulated PYR and PYR-colloidal suspension was concomitantly evaluated against LLC-MK2 lineage and mouse peritoneal macrophage showing that the cells had similar tolerance for both PYR encapsulated or in the aqueous suspension. CF1 mice acutely infected with tachyzoites of Toxoplasma gondii RH strain treated with different doses (5.0-10 mg/kg/day) of PYR-nanocapsules had survival rate higher than the animals treated with the same doses of non-encapsulated PYR. Thus, encapsulation of PYR improved the efficacy of this drug against an acute model of toxoplasmosis in mice and can be considered an alternative for reducing the dose of PYR, which, in turn, could also reduce the side effects associated to the treatment.

引用

页码：555 / 564

页数：10

共 50 条

[41] Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase the stability of statins
Lorenzoni, Ricardo
Cordenonsi, Leticia Malgarim
Davies, Samuel
Antonow, Michelli Barcelos
Medina Diedrich, Aline Scheinder
Santos, Cayane Genro
Vitalis, Graciela Schneider
Garrastazu, Gabriela
Buttini, Francesca
Sonvico, Fabio
Gomes, Patricia
Raffin, Renata Platcheck
JOURNAL OF MICROENCAPSULATION, 2019, 36 (04) : 317 - 326
[42] Ursolic acid-loaded lipid-core nanocapsules reduce damage caused by estrogen deficiency in wound healing
Carletto, Bruna
Koga, Adriana Yuriko
Novatski, Andressa
Mainardes, Rubiana Mara
Lipinski, Leandro Cavalcante
Farago, Paulo Vitor
COLLOIDS AND SURFACES B-BIOINTERFACES, 2021, 203
[43] How Sorbitan Monostearate Can Increase Drug-Loading Capacity of Lipid-Core Polymeric Nanocapsules
Poletto, Fernanda S.
de Oliveira, Catiuscia P.
Wender, Heberton
Regent, Dorothee
Donida, Bruna
Teixeira, Sergio R.
Guterres, Silvia S.
Rossi-Bergmann, Bartira
Pohlmann, Adriana R.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2015, 15 (01) : 827 - 837
[44] Tretinoin-loaded lipid-core nanocapsules decrease reactive oxygen species levels and improve bovine embryonic development during in vitro oocyte maturation
Lucas, Caroline Gomes
Remiao, Mariana Haerter
Komninou, Eliza Rossi
Domingues, William Borges
Haas, Cristina
Moura de Leon, Priscila Marques
Campos, Vinicius Farias
Ourique, Aline
Guterres, Silvia S.
Pohlmann, Adriana R.
Basso, Andrea Cristina
Seixas, Fabiana Koemmling
Ruver Beck, Ruy Carlos
Collares, Tiago
REPRODUCTIVE TOXICOLOGY, 2015, 58 : 131 - 139
[45] Oral Treatment of Spontaneously Hypertensive Rats with Captopril-Surface Functionalized Furosemide-Loaded Multi-Wall Lipid-Core Nanocapsules
Michalowski, Cecilia B.
Arbo, Marcelo D.
Altknecht, Louise
Anciuti, Andreia N.
Abreu, Angelica S. G.
Alencar, Luciana M. R.
Pohlmann, Adriana R.
Garcia, Solange C.
Guterres, Silvia S.
PHARMACEUTICS, 2020, 12 (01)
[46] LC-MS/MS METHOD APPLIED TO PRECLINICAL PHARMACOKINETIC INVESTIGATION OF OLANZAPINE-LOADED LIPID-CORE NANOCAPSULES
Dimer, Frantiescoli A.
Pigatto, Maiara C.
Pohlmann, Adriana R.
Costa, Teresa Dalla
Guterres, Silvia S.
QUIMICA NOVA, 2014, 37 (08): : 1371 - 1376
[47] Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model
Boechat, Antonio Luiz
de Oliveira, Catiuscia Padilha
Tarrago, Andrea Monteiro
da Costa, Allyson Guimaraes
Malheiro, Adriana
Guterres, Silvia Staniscuaski
Pohlmann, Adriana Raffin
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 : 6603 - 6614
[48] Enhanced anti-inflammatory benefits of meloxicam-loaded lipid-core nanocapsules in a mouse pleurisy model: A comparative study with a free form drug
Ianiski, Francine Rodrigues
da Silva, Fernanda D'Avila
Wilhelm, Ethel Antunes
Fernandes, Renata Streck
Alves, Marta Palma
Mederios Frescura Duarte, Marta Maria
Luchese, Cristiane
JOURNAL OF APPLIED BIOMEDICINE, 2016, 14 (02) : 105 - 112
[49] Spray-Dried Powders Containing Tretinoin-Loaded Engineered Lipid-Core Nanocapsules: Development and Photostability Study
Marchiori, M. C. L.
Ourique, A. F.
da Silva, C. de B.
Raffin, R. P.
Pohlmann, A. R.
Guterres, S. S.
Beck, R. C. R.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2012, 12 (03) : 2059 - 2067
[50] Encapsulation in lipid-core nanocapsules improves topical treatment with the potent antileishmanial compound CH8
Escrivani, Douglas O.
Lopes, Milene Valeria
Poletto, Fernanda
Ferrarini, Stela Regina
Sousa-Batista, Ariane J.
Steel, Patrick G.
Guterres, Silvia Staniscuaski
Pohlmann, Adriana Raffin
Rossi-Bergmann, Bartira
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2020, 24

← 1 2 3 4 5 →